Gainers
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
IVERIC bio, Inc. (NASDAQ: ISEE) rose 66.3% to close at $15.70 on Tuesday after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA).
HyreCar Inc. (NASDAQ: HYRE) climbed 58.1% to close at $1.27 on Tuesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
Spero Therapeutics, Inc. (NASDAQ: SPRO) gained 55.5% to close at $1.13. Spero Therapeutics received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection (cUTI).
ChannelAdvisor Corporation (NYSE: ECOM) shares jumped 55% to settle at $22.79 after the company announced it will be acquired by CommerceHub for $23.10 per share.
Akumin Inc. (NASDAQ: AKU) climbed 37% to close at $1.63. Akumin recently received notification letter from the Nasdaq confirming that company had regained compliance with minimum bid price requirement.
Apexigen, Inc. (NASDAQ: APGN) rose 34.4% to close at $7.03.
First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 32.7% to close at $4.22 after gaining 7% on Friday.
Galera Therapeutics, Inc. (NASDAQ: GRTX) jumped 29.5% to settle at $1.67. Galera Therapeutics, last month, posted a Q2 loss of $0.54 per share.
HilleVax, Inc. (NASDAQ: HLVX) rose 24.8% to close at $17.05. HilleVax recently said Safety Data Monitoring Committee has recommended continuation of NEST-IN1 Phase 2b clinical trial.
T Stamp Inc. (NASDAQ: IDAI) gained 24.6% to close at $1.72.
Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) jumped 24.6% to close at $3.49.
Avaya Holdings Corp. (NASDAQ: AVYA) gained 24% to close at $2.12.
Avalo Therapeutics, Inc. (NASDAQ: AVTX) rose 22.3% to settle at $5.87.
Avalo advanced BTLA agonist fusion protein (AVTX-008) to IND-enabling stage.
BioVie Inc. (NASDAQ: BIVI) rose 21.6% to close at $3.44.
Ainos, Inc. (NASDAQ: AIMD) gained 21.1% to close at $2.24. Ainos recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for treatment of mild symptoms related to COVID-19.
Neonode Inc. (NASDAQ: NEON) jumped 18.7% to settle at $4.26. Neonode, last month, posted a Q2 loss of $0.11 per share.
Grove Collaborative Holdings, Inc. (NYSE: GROV) gained 18.4% to close at $5.80.
a.k.a. Brands Holding Corp. (NYSE: AKA) surged 17.4% to settle at $2.36.
SelectQuote, Inc. (NYSE: SLQT) climbed 16.8% to settle at $1.11. SelectQuote recently said Q4 sales results were lower year-over-year and issued FY23 sales guidance below analyst estimates.
ADT Inc. (NYSE: ADT) rose 16.4% to close at $8.39 after the company announced it has secured investments totaling $1.5 billion from State Farm and Google.
Dermata Therapeutics, Inc. (NASDAQ: DRMA) gained 15.3% to close at $0.70. Dermata Therapeutics recently posted a Q2 loss of $0.24 per share
Regulus Therapeutics Inc. (NASDAQ: RGLS) gained 14.1% to close at $1.62. Regulus Therapeutics, last ...
Benzinga
